Form D · Other Health Care
Elevation Oncology, Inc.
New York, NY · CIK 0001783032
Offering snapshot reported Nov 18, 2020 · SEC filing
- Reported sold
- $65M Offering amount: $65M
- Investors reported
- 24 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 10, 2020 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 18, 2020 | Initial | $65,000,000 | No comparison | 24 | SEC filing |
| Jul 19, 2019 | Initial | $5,450,000 | No comparison | 7 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-380915
Source: Form D, filed Nov 18, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Michael Caldwell | Director |
| Timothy Clackson | Director |
| Steven Elms | Director, Executive, Promoter |
| Richard Gaster | Director |
| Lori Hu | Director |
| Shawn Leland | Director, Executive, Promoter |
| Andrew Phillips | Director |
| Colin Walsh | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
888 Seventh Ave 12 Th Floor
New York, NY, 10106
New York, NY, 10106